ERNAW — Ernexa Therapeutics Inc. Warrants

Is ERNAW overbought or oversold? Here is the current MarketMoodz read.

Health Care

Neutral As of July 5, 2026

Ernexa Therapeutics Inc. Warrants (ERNAW) currently reads Neutral on the MarketMoodz overbought/oversold meter, as of July 5, 2026. The Health Care name last closed at $0.04. The rating moved from Oversold to Neutral on May 12, 2026 and has changed 1 time in the last 90 days.

Public ratingNeutral (as of July 5, 2026)
Last close$0.04
Rating changesRating changed 1 time in the last 90 days
Last changeMoved from Oversold to Neutral on May 12, 2026
SectorHealth Care

See today's live rating, score and targets

Members see the live hourly rating for ERNAW — the numeric AI score plus targets and entry zones — while this public page updates nightly.

Start the 14-day trial

This page is for informational purposes only and is not investment, financial, tax, or legal advice. Ratings and research outputs can be wrong, incomplete, or stale. Past performance does not guarantee future results. Always do your own research and consider consulting a qualified professional.